Corticosteroid-induced osteoporosis: Pathogenesis and prevention

Clinical and Experimental Rheumatology

Volumn 18, Issue SUPPL. 20, 2000, Pages

  Benvenuti, S ^a   Brandi, M L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bone cells; Glucocorticoids

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 1; OSTEOCALCIN; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

BONE REMODELING; CONFERENCE PAPER; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG INDUCED DISEASE; MYELOMA; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

GLUCOCORTICOIDS; HUMANS; OSTEOBLASTS; OSTEOPOROSIS;

EID: 0033838815     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)
2. Vertebral fractures resulting from prolonged cortisone and corticotropins therapy
3. Management of corticosteroid-induced osteoporosis
4. Bone loss in response to long-term glucocorticoid therapy
5. Glucorticoid-induced osteoporosis
6. Corticosteroid osteoporosis
7. Bone formation in hypercortisonism
8. Cortisol decreases bone formation by inhibiting perosteal cell proliferation
9. Cortisol represses insulin-like growth factor II receptor transcription in skeletal cell cultures
10. Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid
11. Osteoprotegerin mRNA is expressed in primary human OB-like cells: Down-regulation by glucocorticoids
12. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma
13. Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and OB-enriched cells
14. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol and calcitonin
15. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis